Drugs / CIC Vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06291857 | Dec 2024 → Dec 2025 | COVID-19 | Novavax | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CIC Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06291857 ↗ |
| Modality | Vaccine | “new combination vaccine” NCT06291857 ↗ |
| Route | Intramuscular | “single intramuscular (IM) injection on Day 0” NCT06291857 ↗ |